Catalyst Wire Dossier Catalyst Wire Dossier

BLI1100

· Braintree Laboratories
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BLI1100, covering 2012-10-01 to 2015-02-02. Get the full timeline:

Most recent: Clinical Trial Update: BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris [Phase 2]

See pricing